U.S. markets open in 2 hours 29 minutes

Medtronic plc (MDT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
130.22+2.15 (+1.68%)
At close: 4:00PM EDT
130.16 -0.06 (-0.05%)
Pre-Market: 07:00AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close128.07
Open127.81
Bid0.00 x 900
Ask0.00 x 800
Day's Range127.69 - 130.93
52 Week Range94.64 - 132.30
Volume4,152,045
Avg. Volume4,297,827
Market Cap175.003B
Beta (5Y Monthly)0.81
PE Ratio (TTM)48.95
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.52 (1.94%)
Ex-Dividend DateJun 24, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-18% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • 10 Best Dividend Aristocrats with Over 4% Yield
    Insider Monkey

    10 Best Dividend Aristocrats with Over 4% Yield

    In this article, we will be looking at the 10 best dividend aristocrats with over 4% yield. If you want to skip our detailed analysis of dividend investing, you can go directly to the 5 Best Dividend Aristocrats with Over 4% Yield. According to data from a book called Active Value Investing: Making Money in […]

  • Medtronic (MDT) Introduces New Drug Coated Balloon Catheter
    Zacks

    Medtronic (MDT) Introduces New Drug Coated Balloon Catheter

    Medtronic's (MDT) newly-launched Prevail DCB demonstrates impressive safety and drug deliverability, utilizing a rapid absorption drug to treat patients with coronary artery disease.

  • Medtronic's Antibacterial Envelope Effective In Reducing Infections In Cardiac Device Patients With Hematomas
    Benzinga

    Medtronic's Antibacterial Envelope Effective In Reducing Infections In Cardiac Device Patients With Hematomas

    Medtronic plc (NYSE: MDT) has announced new data from the WRAP-IT study published in Heart Rhythm. The study evaluated Tyrx absorbable antibacterial envelope, an absorbable, single-use device that holds a cardiac implantable electronic device or implanted neurostimulator. It is designed to stabilize the device after implantation while releasing antibacterial agents, minocycline, and rifampin, over a minimum of seven days. Data demonstrated a significantly lower infection risk for patients who de